Retrospective cohort study finds incidence of herpes zoster impacts healthcare utilization in adults, highlighting the need for vaccination.
The risk of herpes zoster (HZ) and its complications increases with age and is higher in individuals with specific comorbidities. Recent population-level data for HZ disease and health economic burden in Taiwan are limited. We aimed to estimate the incidence of HZ and HZ-related complications, and HZ-related healthcare resource utilization, in the general adult population aged ≥18 years, including subgroup analyses of adults with immunocompromised (IC) conditions, autoimmune diseases (AID) and chronic conditions (CC) in Taiwan. This retrospective, population-based cohort study used claims data from Taiwan's National Health Insurance database between 1 January 2010 and 31 December 2020. The analysis included 1,693,166 adults aged ≥18 years with a primary HZ diagnosis from 2011 to 2020, including 653,414 HZ patients with IC conditions/AID/CC. HZ incidence rates increased over time in the general adult (2011-2020: 7.15-7.82/1,000 person-years [PY], p < .0001) and IC/AID/CC (2011-2019: 9.01-10.28/1,000 PY) populations. Older adults (aged ≥50 years) and patients with IC conditions/AID/CC (versus younger adults aged 18-49 years and the general adult population, respectively) demonstrated higher incidence of HZ and HZ-related complications, and healthcare utilization. Individuals with specific underlying IC conditions/AID/CC (e.g. human immunodeficiency virus infection [24.52/1,000 PY]) had substantially higher HZ incidence rates than others (e.g. stroke [8.39/1,000 PY]). Patients with HZ developing postherpetic neuralgia (versus non-pain complications) had substantially greater outpatient visits and associated costs. Findings demonstrate the considerable disease and health economic burden of HZ in Taiwan, particularly in older adults and the IC/AID/CC population. These results highlight the need for strengthening prevention strategies, with vaccination as a key public health intervention, to reduce HZ incidence and complications.
No takes yet. Share an insight, caveat, or question.
Hsiao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: